PTAB

IPR2018-01313

CSL Behring LLC, CSL Behring GmbH, and CSL Behring Recombinant Facility AG v. Bioverativ Therapeutics, Inc.

General
Filed
07/02/18
Institution01/09/19
FWD--
Close01/09/19
StatusInstitution Denied
OutcomeDenied
USPTOIPR2018-01313
Administrative Patent Judges
Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Judge
Cases
Inst. Rate
FWD Inv. Rate
Georgianna W Braden
500+
50%
50%
Michelle N Ankenbrand
500+
50%
50%
Wesley B Derrick
500+
50%
50%
Petitioner
Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Party
Name
Ratings
CSL Behring Recombinant Facility AG 
L3
E
CSL Behring LLC 
L3
E
CSL Behring GmbH 
L3
E
No Parties
Attorney
Name
Ratings
Wilmer Cutler Pickering Hale Dorr LLP
L5
A
Patrick J. Coyne
L5
A
No Attorneys
Respondent
Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Party
Name
Ratings
Bioverativ Therapeutics Inc 
L3
C
No Parties
Attorney
Name
Ratings
Foley Hoag LLP
L5
A
Patrick J. Coyne
L5
A
No Attorneys